April 2022
Myeloproliferative Neoplasms (MPNs)
Clinical trials play a vital role in moving treatment and research advances forward. The Clinical Trials 201 program tackles common misconceptions and provides clear, actionable information about trials, sharing tools and resources for patients with essential thrombocythemia (ET), polycythemia vera (PV), and myelofibrosis (MF) who are considering clinical trial participation. Clinical Trials 201 includes: